Jan. 16, 2024, 1:49 a.m. | Alex McFarland

Unite.AI www.unite.ai

Researchers at the University of Cambridge have developed an AI-driven platform that dramatically accelerates the prediction of chemical reactions, a crucial step in drug discovery. Moving away from traditional trial-and-error methods, this innovative approach combines automated experiments with machine learning. This advancement, validated on over 39,000 pharmaceutically relevant reactions, could significantly streamline the process of […]


The post AI-Driven Platform Could Streamline Drug Development appeared first on Unite.AI.

advancement automated cambridge chemistry development discovery drug development drug discovery error healthcare machine machine learning moving platform prediction process researchers university university of cambridge

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Sr. BI Analyst

@ AkzoNobel | Pune, IN